Lupin Approved for Potassium Chloride Extended Release Caps

pill bottles
pill bottles

Lupin announced that it has received final approval from the Food and Drug Administration (FDA) for its Potassium Chloride Extended Release Capsules, which is a generic version of Actavis' Potassium Chloride Extended Release Capsules.

Potassium Chloride Extended Release Capsules are indicated for the treatment of hypokalemia, with or without metabolic alkalosis, in patients with digitalis intoxications or hypokalemic familial periodic paralysis. It is also indicated for the prevention of hypokalemia in at-risk patients.

RELATED: Unit Dose Version of KCL Solution Launched 

Potassium Chloride Extended Release Capsules will be available in 8mEq and 10mEq strengths.

For more information call (800) 399-2561 or visit Lupinpharmaceuticals.com.

Loading links....